Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – In an organic compound
Patent
1996-08-22
1998-11-17
Hollinden, Gary E.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
In an organic compound
530326, 424 165, 534 14, A61K 5100, A61M 3614
Patent
active
058372180
ABSTRACT:
Detectably labelled non-receptor mediated cell-associating compounds are provided for use in the diagnostic imaging of target sites in a mammal. Cell-associating compounds may be directly labelled, or labelled via a chelating compound to form a conjugate. Such cell-associating compounds are particularly useful to image target sites such as tumour sites and sites of infection.
REFERENCES:
patent: 4810777 (1989-03-01), Zasloff
patent: 5043176 (1991-08-01), Bycroft et al.
patent: 5180816 (1993-01-01), Dean
patent: 5277892 (1994-01-01), Rhodes
patent: 5447914 (1995-09-01), Travis et al.
patent: 5585353 (1996-12-01), Merrifield et al.
patent: 5688489 (1997-11-01), Peers et al.
Goodbody Anne
Peers Susan H.
Pollak Alfred
Thornback John
Hollinden Gary E.
Jones Dameron
Resolution Pharmaceuticals Inc.
LandOfFree
Non-receptor cell mediated imaging agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Non-receptor cell mediated imaging agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Non-receptor cell mediated imaging agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-881192